Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Girolamo, Arrigo"'
Autor:
Bruna Bollini, Girolamo Arrigo, Renato Alberto Sinico, Caterina Corace, Antonella Radice, Masami Ikehata, Maurizio Li Vecchi, Gaia Giammarresi
Publikováno v:
Annals of the New York Academy of Sciences. 1050:193-200
Recently, anti-C1q autoantibodies have been proposed as a useful marker in systemic lupus erythematosus (SLE) since their occurrence correlates with renal involvement and, possibly, with nephritic activity. We aimed to evaluate the prevalence of anti
Autor:
Girolamo Arrigo, Amedeo Bongarzoni, Chiara Forgione, Claudio Cuccia, Irene Floriani, Franco Casazza, Luigi Pignataro, Ferdinando Imperadore
Publikováno v:
Thrombosis research. 134(6)
Aims The aim of the study is to describe the course of the echocardiographically measured pulmonary artery systolic pressure (PAsP) in a series of patients included in the Italian Pulmonary Embolism Registry (IPER). Methods Patients with confirmed PE
Publikováno v:
Kidney International. 58:S41-S46
Adequacy in hemodialysis: New concepts derived from online urea monitoring. Background The estimation of urea kinetic parameters [urea generation rate (G u ), normalized protein catabolic rate (NPCR), and dialysis dose (Kt/V)] is routinely performed
Autor:
Giuseppe D'Amico, Sandro Amaducci, Benedetta Colombo, Girolamo Arrigo, Elisabetta Moreni, Claudio Bazzi
Publikováno v:
American Journal of Kidney Diseases. 24:802-805
Several mechanisms (trapping of neutrophils, increased extravascular lung water, left ventricular hypertrophy, metastatic lung calcification, and iron deposition) may impair pulmonary function and alter bronchial responsiveness in patients on long-te
Autor:
Marida Quarenghi, Giuseppe D'Amico, Gina Gregorini, Girolamo Arrigo, Maged Tadros, Cristiana Pozzi, Antonella Radice, Renato Alberto Sinico, Cristina Comotti, Aldo Castiglione
Publikováno v:
Clinical Immunology and Immunopathology. 73:19-26
To verify whether IgA antineutrophil cytoplasmic antibody (ANCA) represents a serologic marker in Henoch-Schönlein purpura (HPS), we examined sera from 41 patients with the disease. Control sera from 28 patients with primary IgA nephropathy (IgA-N),
Publikováno v:
American Journal of Nephrology. 13:198-202
Blood lead corrected for hematocrit (PbC) was measured in 115 hemodialysis (HD) patients. Information was collected with a questionnaire about personal and environmental factors thought to influence blood Pb levels. HD patients had significantly high
Autor:
Antonion, Giordano, Girolamo, Arrigo, Fausto, Lavarda, Giuliano, Colasanti, Concetta, Petrini
Publikováno v:
Journal of nephrology. 18(2)
Iron supplementation in chronic hemodialyzed patients is not yet completely defined concerning the dosing regimen. This study aimed to evaluate the effects of the same iron load administered in different regimens on anemia, iron status and the reticu
Autor:
Girolamo Arrigo, Giuseppe D'Amico, Pietro Napodano, Concetta Petrini, Maria Paparella, Lucia Pisano, Virginia Rizza, Claudio Bazzi
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 41(2)
Background: Prolonged treatment with steroids and/or cyclophosphamide improves the prognosis of primary focal segmental glomerulosclerosis (FSGS). In nephrotic patients, no clinical or histological feature predicts responsiveness to therapy. Methods:
Publikováno v:
Monoclonal Gammopathies and the Kidney ISBN: 9789048161997
Light chain deposition disease (LCDD) is a systemic disorder characterized by deposition of monotypic immunoglobulin light chain (LC) in several organs, and in particular in the kidney1–4. LCDD is part of a large and heterogeneous group of diseases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e248d5018a36f498076150c4403d8ab
https://doi.org/10.1007/978-94-017-0191-4_11
https://doi.org/10.1007/978-94-017-0191-4_11
Autor:
Girolamo Arrigo, Virginia Rizza, Maria Paparella, Claudio Bazzi, Pietro Napodano, Giuseppe D'Amico, Concetta Petrini
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 17(11)
Background. The urinary excretion of N-acetyl-bglucosamynidase (NAG) is increased in subjects exposed to substances toxic for renal tubular cells. In experimental and human glomerular diseases, its increased excretion is probably due to the dysfuncti